XTX Topco’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-14,378
Closed -$95.6K 2048
2024
Q2
$95.6K Buy
+14,378
New +$106K 0.01% 1424
2023
Q4
Sell
-204,998
Closed -$533K 1545
2023
Q3
$533K Buy
+204,998
New +$588K 0.09% 360
2023
Q2
Sell
-21,271
Closed -$89.8K 1380
2023
Q1
$89.8K Buy
+21,271
New +$253K 0.02% 1112
2022
Q2
Sell
-19,665
Closed -$120K 829
2022
Q1
$120K Buy
19,665
+4,898
+33% +$36.1K 0.05% 485
2021
Q4
$135K Buy
+14,767
New +$157K 0.08% 419

Other funds holding ALT

XTX Topco's ALT Position: Q3 2024 in Review

XTX Topco sold out of Altimmune (ALT) in Q3 2024, closing a stake of 14,378 shares — an estimated $95.6K sold.

XTX Topco first reported a position in ALT in Q4 2021 and held it in 5 quarters. The position peaked at $533K in Q3 2023. 169 funds tracked by Wall St. Rank hold ALT as of Q3 2024.

  • XTX Topco reported no remaining Altimmune position as of Q3 2024 after selling out during the quarter.
  • XTX Topco sold 14,378 Altimmune shares in Q3 2024, an estimated $95.6K.
  • XTX Topco first reported a position in Altimmune in Q4 2021 and held it in 5 quarters.
  • XTX Topco's Altimmune position peaked at $533K in Q3 2023.
  • 169 funds tracked by Wall St. Rank held Altimmune as of Q3 2024.

Based on XTX Topco's 13F filing for Q3 2024, filed 14 Nov 2024.